Exosomes are extracellular vesicles capable of crossing the blood–brain barrier and carrying ALS-related biomarkers (e.g., TDP-43, NfL, miRNAs), offering a promising, non-invasive, and cell-specific approach for early diagnosis and disease monitoring. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.